Skip to content

Human clinical study on plasma coenzyme Q10 concentrations

Human clinical study on plasma coenzyme Q10 concentrations - Human clinical study on plasma coenzyme Q10 concentrations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043690
Enrollment
60
Registered
2022-02-01
Start date
2021-03-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

None listed

Sponsors

KANEKA CORPORATION
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Healthy male and female aged of 20 to 60 years. 2.Subjects who agreed to participate in the study in writing prior to the start of the trial with sufficient understanding of the purpose and contents of this study.

Exclusion criteria

Exclusion criteria: 1.Subjects taking supplements containing CoQ10 3 months prior to the study. 2.Subjects who receiving drug treatment. 3.Subjects who participating in any other clinical study/trial or within 4 weeks after participating in another study. 4.Subjects who have history of present illness and past medical history that affect digestion and absorption of diet. 5.Subjects who cannot eat orally. 6.Subjects who are in pregnant, breast feeding, or expect to be pregnant during the study. 7.Subject who have smoking habits. 8.Subjects who continue high-intensity exercise regularly. 9.Subjects judged inappropriate for this study by the principal investigator.

Design outcomes

Primary

MeasureTime frame
CoQ10 levels

Secondary

MeasureTime frame
CoQ10 levels in various areas

Countries

Japan

Contacts

Public ContactTakao Yamaguchi

KANEKA CORPORATION Pharma & Supplemental Nutrition Solutions Vehicle

Takao.Yamaguchi@kaneka.co.jp050-3133-7356

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026